Infectious Diseases News and Research

RSS

Observational study uncovers largest outbreak of neurologic illness to date in the U.S.

The Lancet Infectious Diseases recently published the results of an observational study led by researchers on Children's Hospital Colorado Infectious Disease and Neurology teams, along with counterparts at the Centers for Disease Control and Colorado Department of Public Health and Environment.

8 Jan 2020

New nanotech technique fights advanced-stage sepsis

Scientists have found a novel approach using nanotechnology that can fight late-stage sepsis.

8 Jan 2020

Study reveals new mechanism that controls the causes of stomach disease

Infectious diseases triggered by bacteria and other microbes are the most frequent cause of human mortality across the globe.

8 Jan 2020

Intervention for hospitalized HIV patients reduces infection rates and increases engagement in care

Providing multidisciplinary team consults for HIV patients while they are hospitalized to help address social and medical barriers reduces future infection rates and boosts participation in follow-up care, results from a study on how to reengage patients show.

7 Jan 2020

New Yorkers are being treated sooner after HIV infection, study shows

The most effective way to reduce HIV-related deaths and prevent onward transmission is to diagnose and treat all persons as soon as possible after HIV infection. According to a study published in Clinical Infectious Diseases, New Yorkers living with HIV are being treated sooner after infection.

7 Jan 2020

Clinical trial tests experimental stem cell treatment against best available drugs for MS

A clinical trial has begun testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis.

7 Jan 2020

NYU Langone Health announces launch of a multidisciplinary Vaccine Center

Building on its illustrious landmark-achieving history in the field of immunology, NYU Langone Health announced today the launch of a Vaccine Center that combines basic research, clinical studies, and public health outreach to prevent the spread of infectious diseases and other immunological disorders.

7 Jan 2020

Novel nanoparticle vaccine provides long-lasting protection against influenza virus

A novel nanoparticle vaccine that combines two major influenza proteins is effective in providing broad, long-lasting protection against influenza virus in mice, showing promise as a universal flu vaccine, according to a study by the Institute for Biomedical Sciences at Georgia State University.

7 Jan 2020

ART may not be completely effective in restoring immune protection, study suggests

A study led by researchers from SUNY Downstate Health Sciences University and Oregon Health & Science University, published in the Journal of Infectious Diseases, showed that, despite successful antiretroviral therapy, antigen specific memory to vaccinations that occurred before HIV infection did not recover, even after immune reconstitution.

6 Jan 2020

Study underscores the importance of long-term follow-up for Zika-exposed infants

Colombian infants exposed to Zika virus in the womb showed neurodevelopmental delays as toddlers, despite having "normal" brain imaging and head circumference at birth, a finding that underscores the importance of long-term neurodevelopmental follow-up for Zika-exposed infants, according to a study published online Jan. 6, 2020, in JAMA Pediatrics.

6 Jan 2020

CDC warns that current flu season is due to be particularly long and severe

The current flu season is on track to be one of the most severe in years, according to new data from the CDC.

6 Jan 2020

Intravenous BCG vaccine provides greater protection against tuberculosis

Researchers have found that the BCG vaccine is more efficacious in the prevention of TB when administered intravenously.

2 Jan 2020

Intravenous administration boosts protective power of TB vaccine

Worldwide, more people die from tuberculosis than any other infectious disease, even though the vast majority were vaccinated.

2 Jan 2020

Bile acids help norovirus to infect cells of the small intestine

A new study led by researchers at Baylor College of Medicine and published in the Proceedings of the National Academy of Sciences reveals that human noroviruses, the leading viral cause of foodborne illness and acute diarrhea around the world, infect cells of the small intestine by piggybacking on a normal cellular process called endocytosis that cells use to acquire materials from their environment.

31 Dec 2019

Diarrhea in young children linked to La Niña climate conditions

A study in Botswana by Columbia University Mailman School of Public Health scientists finds that spikes in cases of life-threatening diarrhea in young children are associated with La Niña climate conditions.

30 Dec 2019

CD4 T cells are not to be blamed for pushing dengue fever from bad to worse

No one knows what makes a mild dengue viral infection morph into a severe and sometimes deadly dengue hemorrhagic fever/dengue shock syndrome.

26 Dec 2019

Certain bacteria can override programmed cell death

Certain bacteria can override a defense mechanism of the immune system, so called programmed cell death, through inhibition of death effector molecules by their outer membranes components.

26 Dec 2019

Immunologists discover new RIPK1 mechanism that leads to cell death

Scientists at St. Jude Children's Research Hospital have discovered a new way that the molecule RIPK1 leads to cell death in infected, damaged or unwanted cells showing that more than one mechanism can trigger the process.

23 Dec 2019

California's vaccine policy improved immunization coverage

In 2016, California removed vaccine exemptions for non-medical reasons, such as parental hesitancy, to requirements for school entry. In other words, California children needed to have a medical reason to refuse vaccination if they wanted to join kindergarten. In so doing, the state may have paved the way for a higher percentage of vaccination recipients at both county and state level, says a new study published this week in the journal PLOS Medicine.

23 Dec 2019

NIAID to fund VTEU program and its companion leadership group

The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, today announced the establishment of the Infectious Diseases Clinical Research Consortium, a clinical trials network that will encompass the Institute's long-standing Vaccine and Treatment Evaluation Units (VTEUs) and create a new consortium leadership group

20 Dec 2019